DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HYDROCORTISONE ACETATE; UREA
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
HYDROCORTISONE ACETATE; UREA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M RED BLOOD CELL KIT
4
Unknown
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M RED BLOOD CELL KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ALA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MENATETRENONE
4
Small molecule
Approved
Unknown
Unknown
Carcinoma, Hepatocellular; Bone Diseases; Osteoporosis; Osteoporosis, Postmenopausal
Unknown
MENATETRENONE
×
Maximum Phase:
4
First Approval:
None
UNII:
27Y876D139
Molecule Type:
Small molecule
Molecular Formula:
C31H40O2
Molecular Weight:
444.66
AlogP:
8.92
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
11.0
Source:
ANTHRALIN
4
Small molecule
Approved
Unknown
Unknown
Psoriasis
Unknown
ANTHRALIN
×
Maximum Phase:
4
First Approval:
None
UNII:
U8CJK0JH5M
Molecule Type:
Small molecule
Molecular Formula:
C14H10O3
Molecular Weight:
226.23
AlogP:
2.23
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
0.0
Source:
SOC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SOC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOFETAMINE HYDROCHLORIDE I-123
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IOFETAMINE HYDROCHLORIDE I-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROMOSOZUMAB-AQQG
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ROMOSOZUMAB-AQQG
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM IODIDE I 131
4
Small molecule
Approved
Unknown
Unknown
Adenocarcinoma, Follicular; Hyperthyroidism; Thyroid Neoplasms
Unknown
SODIUM IODIDE I 131
×
Maximum Phase:
4
First Approval:
None
UNII:
29VCO8ACHH
Molecule Type:
Small molecule
Molecular Formula:
INa
Molecular Weight:
153.9
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BILASTINE
4
Small molecule
Approved
Unknown
Unknown
Cold Urticaria; Conjunctivitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria; Eye Manifestations; Hypersensitivity
Histamine H1 receptor inverse agonist
BILASTINE
×
Maximum Phase:
4
First Approval:
None
UNII:
PA1123N395
Molecule Type:
Small molecule
Molecular Formula:
C28H37N3O3
Molecular Weight:
463.62
AlogP:
4.86
PSA:
67.59
HBD:
1.0
HBA:
#RotB:
10.0
Source:
BUTETHAL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BUTETHAL
×
Maximum Phase:
4
First Approval:
None
UNII:
OHZ8QAW6YC
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O3
Molecular Weight:
212.25
AlogP:
0.94
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ACEMETACIN
4
Small molecule
Approved
Unknown
Unknown
Rheumatic Diseases
Cyclooxygenase inhibitor
ACEMETACIN
×
Maximum Phase:
4
First Approval:
None
UNII:
5V141XK28X
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClNO6
Molecular Weight:
415.83
AlogP:
3.47
PSA:
94.83
HBD:
1.0
HBA:
#RotB:
6.0
Source:
INSULIN GLARGINE; LIXISENATIDE
4
Combination
Approved
Unknown
SUBCUTANEOUS
Unknown
Unknown
INSULIN GLARGINE; LIXISENATIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COPPER
4
Small molecule
Approved
OTHER
INTRAUTERINE
Amyotrophic Lateral Sclerosis; Vaginosis, Bacterial; Alzheimer Disease; Breast Neoplasms; Glioblastoma; Paraganglioma; Prostatic Neoplasms, Castration-Resistant
Unknown
COPPER
×
Maximum Phase:
4
First Approval:
None
UNII:
789U1901C5
Molecule Type:
Small molecule
Molecular Formula:
Cu+2
Molecular Weight:
63.55
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALAMINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CALAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETIC ACID
4
Small molecule
Approved
Unknown
Unknown
Wounds and Injuries; Chemical and Drug Induced Liver Injury; Skin Ulcer; Inflammation
Unknown
ACETIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Q40Q9N063P
Molecule Type:
Small molecule
Molecular Formula:
C2H4O2
Molecular Weight:
60.05
AlogP:
0.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
AMINOBENZOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
AMINOBENZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
TL2TJE8QTX
Molecule Type:
Small molecule
Molecular Formula:
C7H7NO2
Molecular Weight:
137.14
AlogP:
0.97
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TAFASITAMAB-CXIX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TAFASITAMAB-CXIX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROSE; POTASSIUM CHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; POTASSIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
QUININE DIHYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
QUININE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
8C3EMH7D9X
Molecule Type:
Small molecule
Molecular Formula:
C20H26Cl2N2O2
Molecular Weight:
397.35
AlogP:
3.17
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
CARDIOVASCULAR; OTHER
ORAL
Unknown
Unknown
ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLPREDNISOLONE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
METHYLPREDNISOLONE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACIPIMOX
4
Small molecule
Approved
Unknown
Unknown
Bulimia Nervosa; Diabetes Mellitus, Type 2; Feeding and Eating Disorders; Heart Failure; Metabolic Syndrome; Diabetes Mellitus, Type 1; Cardiovascular Diseases
Unknown
ACIPIMOX
×
Maximum Phase:
4
First Approval:
None
UNII:
K9AY9IR2SD
Molecule Type:
Small molecule
Molecular Formula:
C6H6N2O3
Molecular Weight:
154.12
AlogP:
-0.28
PSA:
77.13
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CEFSULODIN SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CEFSULODIN SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
2D087186PY
Molecule Type:
Small molecule
Molecular Formula:
C22H19N4NaO8S2
Molecular Weight:
554.54
AlogP:
-0.9
PSA:
190.88
HBD:
3.0
HBA:
#RotB:
8.0
Source:
SODIUM GLUCONATE
4
Small molecule
Approved
Unknown
Unknown
Brain Neoplasms; Hemorrhage
Unknown
SODIUM GLUCONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
R6Q3791S76
Molecule Type:
Small molecule
Molecular Formula:
C6H9NaO7
Molecular Weight:
216.12
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FURSULTIAMINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Supplement
FURSULTIAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
05J61265PX
Molecule Type:
Small molecule
Molecular Formula:
C17H26N4O3S2
Molecular Weight:
398.55
AlogP:
2.5
PSA:
101.57
HBD:
2.0
HBA:
#RotB:
10.0
Source:
CLOMACRAN PHOSPHATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CLOMACRAN PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
7A1GN6M31H
Molecule Type:
Small molecule
Molecular Formula:
C18H24ClN2O4P
Molecular Weight:
398.83
AlogP:
4.87
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ANSUVIMAB-ZYKL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ANSUVIMAB-ZYKL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ANLOTINIB
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ANLOTINIB
×
Maximum Phase:
4
First Approval:
None
UNII:
GKF8S4C432
Molecule Type:
Small molecule
Molecular Formula:
C23H22FN3O3
Molecular Weight:
407.45
AlogP:
4.83
PSA:
82.39
HBD:
2.0
HBA:
#RotB:
6.0
Source:
IOTHALAMATE SODIUM I 125
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
IOTHALAMATE SODIUM I 125
×
Maximum Phase:
4
First Approval:
None
UNII:
31J5U3Q9ZN
Molecule Type:
Small molecule
Molecular Formula:
C11H8I3N2NaO4
Molecular Weight:
631.9
AlogP:
2.52
PSA:
95.5
HBD:
3.0
HBA:
#RotB:
3.0
Source:
NICOFURANOSE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
NICOFURANOSE
×
Maximum Phase:
4
First Approval:
None
UNII:
GF99P6327K
Molecule Type:
Small molecule
Molecular Formula:
C30H24N4O10
Molecular Weight:
600.54
AlogP:
1.82
PSA:
186.22
HBD:
1.0
HBA:
#RotB:
10.0
Source:
CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE
4
Combination
Approved
OTHER
INTRAPERITONEAL
Unknown
Unknown
CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LONAPEGSOMATROPIN-TCGD
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
LONAPEGSOMATROPIN-TCGD
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
295
296
297
298
299
300
301
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA